Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Pachyonychia congenita is caused by pathogenic mutations in one of five specific keratin genes that provide structural integrity to skin and nail cells. These genetic errors disrupt the formation of keratin filaments, leading to the characteristic thickening of nails, painful palmoplantar keratoderma, and other epithelial issues. What causes Pachyonychia Congenita at the genetic level? Pachyonychia congenita is a rare autosomal dominant genetic disorder.
TL;DR: Pachyonychia congenita is caused by pathogenic mutations in one of five specific keratin genes that provide structural integrity to skin and nail cells. These genetic errors disrupt the formation of keratin filaments, leading to the characteristic thickening of nails, painful palmoplantar keratoderma, and other epithelial issues.
Pachyonychia congenita is a rare autosomal dominant genetic disorder. It is caused by mutations in genes that encode keratins, the "scaffolding" proteins that give skin, hair, and nails their strength. When these genes are mutated, the resulting keratin proteins are structurally unstable, causing cells to collapse under the mechanical stress of walking or gripping, which leads to the painful blistering and thickening seen in Pachyonychia Congenita.
The molecular basis of Pachyonychia Congenita involves five specific genes. Mutations in these genes disrupt the keratin intermediate filament network:
While the root cause of Pachyonychia Congenita is strictly genetic, environmental factors can significantly influence the severity of symptoms. Mechanical trauma—such as friction from walking or ill-fitting footwear—is a major trigger for the painful plantar keratoderma and blistering that many of our 4 Pachyonychia Congenita community members experience. Managing these mechanical stressors is a core component of clinical care.
While we understand the specific genes responsible for Pachyonychia Congenita, researchers are still investigating why the same mutation can manifest with varying severity between individuals. Current research is focused on "molecular therapies," such as small interfering RNA (siRNA) and rapamycin, which aim to silence the mutant gene or mitigate the cellular stress caused by Pachyonychia Congenita.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician.